Municipal Medical Research Institute by Camí i Morell, Jordi
The Municipal Medical Research Institute (Catalan acronym:
IMIM) is a public body dedicated to scientific research in the
field of biomedicine and the health sciences. The Institute
also works in the preparation and professional training of re-
search personnel in these areas. Since 1991, it has been
recognized as a higher school of learning by the Consejo de
Universidades. As of July 2000, it was registered with the
Universitat Pompeu Fabra by legal decree of the Generalitat
of Catalonia.
Historical antecedents
The IMIM is currently dependent on the Institut Municipal
d’Assistència Sanitària (IMAS, Municipal Institute of Medical
Assistance), charged with providing support for, promoting,
coordinating, and managing its own intramural research and
that of the Hospital del Mar, the Hospital de l’Esperança, the
Centre Geriàtric, and the Centre Psiquiàtric. The IMIM was
created by the Barcelona City Council in 1947 thanks to the
support of Dr L. García Tornel, then Lieutenant-Mayor for
Health. The moving force behind the Institute was Dr Trias
de Bes who, as director of the Hospital Municipal d’Infec-
ciosos (now the Hospital Universitari del Mar), charged Drs
Jordi Gras i Riera and Amadeo Foz Tena with its creation.
Thus, in 1948, the IMIM was solemnly inaugurated by Sir
Alexander Fleming. In the 1950s and 1960s, the IMIM
played the role of the main biomedical research centre in
Barcelona where the doctoral dissertation in experimental
projects could be presented. At that time, the only two lines
of research at the IMIM were biochemistry (which would later
become immunology) under the supervision of Dr Gras, the
centre’s director until his retirement in 1984, and also bacte-
riology, headed by Dr Foz, a member of the World Health Or-
ganization’s team of experts on brucellosis in 1958. Dr Foz
also played a notable role at the Institute in his studies on the
outbreak of cholera in Barcelona in 1971.
The political transition to a democratic system of govern-
ment, begun in Spain in 1975, also had its translation within
the health system, and in 1986 culminated in the enactment
of the General Law on Health Measures. During those
years, the city councils undertook numerous health initia-
tives such as those oriented toward transforming medical
assistance services. At the end of 1984, the organization of
the IMAS into an autonomous municipal health assistance
body aided in the opening of a specific research policy in
the city hospitals. This process allowed a reorientation of
the activities of the old IMIM by way of the integration of the
pharmacology group of the Hospital del Mar (dedicated to
research on substances of abuse and dependence), the
incorporation of a new group of computer-assisted medi-
cine from the Universitat Autònoma de Barcelona, and the
establishment of a specific budget. The additional incorpo-
ration, in the course of 1987 and 1988, of other research
groups in the areas of cellular biology and of epidemiology
and public health completed the structural base of the pre-
sent Institute.
Since 1985, the IMIM has been accredited by the Interna-
tional Olympic Committee to control doping. It is also the
World Health Organization’s collaborating centre (European
Regional Office) in the area of substances of abuse and de-
pendence. In 1992, the Institute moved into its present build-
ing and carried out the doping control tests for the Para-
lympics and the Olympics organized in Barcelona. One of
the most important scientific events in which the IMIM
played a participatory role was the discovery, in 1987, of the
link between the soybeans unloaded from ships docked at
Barcelona Harbour and acute asthma epidemics (some-
times mortal), a series of outbreaks which were later shown
to have been occurring since 1981.
Organization of research, human resources and
economic resources
During 1995, ten years into this second phase of operations,
a new reorganization was undertaken consisting in the orga-
nization of multidisciplinary research units and groups, a
good part of them of mixed character, with clinical re-
searchers from the hospitals. Currently, and as a conse-
quence of an external evaluation carried out by ANEP in
1988, the IMIM was structured into 11 research units and
groups, 7 of which are accredited by the CIRIT as quality re-
search groups. Thus, the institution is also accredited by the
Ministerio de Sanidad y Consumo as a Mixed Health Re-
search Unit, a qualification awarded to only three centres in
all of Catalonia.
At present, 234 people are employed at the intramural
IMIM. Of these, 128 are contracted personnel, 57 are per-
manent staff, and 71 posts are occupied by temp workers.
Among these 128 contracted workers, 58 are scientific re-
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searchers and the remainder are comprised of technical
support people and those working in administration and ser-
vices. The 106 remaining workers are research grant hold-
ers (higher, middle-level, and post-graduate technicians),
66 of whom are at a predoctoral stage.
As to economic resources, in relation to the 1999 exer-
cise, the expense budget was 1,095.8 million pesetas, of
which 54.1% corresponds to personnel costs and 32.1% to
the acquisition of goods and services. Another 46% of these
costs were financed by way of an IMAS contribution. This fi-
nancing came principally from the Servei Català de Salut
(Generalitat de Catalunya) as a consequence of the agree-
ment for provisioning health service assistance to IMAS. The
remaining 54% of the budget was supported through aid re-
sources and final subsidies, the contracts and research
agreements with private and public institutions as well as the
resources from specialized services, as is the case for the
doping control tests. In total, in 1999, the IMIM generated its
own resources to the amount of 752 million pesetas.
Lines of research, ongoing research projects, and
scientific production
Currently, research is carried out according to the arrange-
ment of 126 externally financed projects (including research
grants and R&D contracts). Of these projects, it is important
to point out that 7 are financed by the EU and coordinated
by the IMIM while an additional 12 projects are financed by
the EU with the IMIM as active participating partner. Aside
from the projects financed by the EU, IMIM scientists have at
their disposal competitive assistance from such public orga-
nizations as the CIRIT, the Health Research Fund, the Na-
tional R&D Plan, (R+D+R), and those of private bodies such
as the Fundació Ramon Areces, the Fundació Marató de
TV3, and the Fundació La Caixa, among others. Research is
also carried out on the basis of aid from the North American
NIH and through contracts and agreements signed with
health firms (mainly pharmaceutical) and with different bod-
ies of the local, autonomous, or central governments.
The Research Units and Groups concentrate their investi-
gations in the following areas: basic research, clinical and
epidemiological cancer research, clinical and epidemiologi-
cal research in pharmaceutics and substances of abuse
and dependence, research on the effectiveness of the
health services, research in cardiovascular diseases, re-
search in respiratory medicine and envirnomental health,
and research in computer-assisted biomedicine.
As to scientific production, more than 300 documents are
published annually. In 1999, 152 of these documents consti-
tuted original research and revisions, 105 of which ap-
peared in international SCI and SSCI indexed journals. The
remainder are other types of working documents, books and
chapters of books, and academic works. Among these, 9
doctoral dissertations (36 since 1996) are highly notable
works. In regard to the research done in the health field, this
scientific production situates the IMIM in third position in
Catalonia and in Spain in biomedical investigations, taking
into account the production/research personnel fraction.
The present and future of the IMIM: its relations
with the Universitat Pompeu Fabra and the
Barcelona Biomedical Research Park project
While it is a university institute, the present IMIM cannot be
understood outside of its direct relationship to the new stud-
ies in the health sciences and the life of the Universitat Pom-
peu Fabra (UPF). These studies were begun on premises
provided by the UPF itself. An academic development that
has involved the creation of the UPF Department of Experi-
mental and Health Sciences, with the incorporation of the
new highly qualified teaching staff made up of research
groups in the same area. Thus, not only are common and
scientific-technical services shared, but the scientific envi-
ronment itself grows annually with expert university profes-
sors in the fields of intracellular tagging, genomic regulation,
and evolutionary biology, among others. Among the UPF’s
academic initiatives with direct IMIM participation is the very
notable doctoral program in the health sciences and the life
sciences. The program is designed to provide training for re-
search personnel and is characterized by its multidiscipli-
nary nature. Three fields of specialization are provided in the
areas of basic research, clinical research, and public health
research respectively. An important recent initiative on the
part of scientists from both institutions is the creation of a
Code of Good Scientific Practices, a set of «game rules»
freely and voluntarily accepted by professors and re-
searchers not only to maintain the integrity of the research
they carry out, but also to guarantee its maximum excellence
and quality. Further information is available from
www.imim.es or www.upf.es/biomed.
Finally, it should be mentioned that the IMIM is one of the
scientific institutions that make up part of the future
Barcelona Biomedical Research Park (Catalan acronym:
PRBB). This project is a joint undertaking of the City Council
of Barcelona, the Generalitat of Catalonia, through the Uni-
versity Departments (conselleries) for Research and Infor-
mation Society, and the Department of Health and Social Se-
curity, the UPF, and the IMAS. The project is being proposed
as a city scientific park designed to reinforce the role of
Barcelona and Catalonia in the fields of research, teaching
and health care excellence. The PRBB will concentrate re-
sources in areas of knnowledge emerging from the fields of
human biology and of medicine and, very particularly, will
make possible genomic and biological developmental re-
search, cancer research, environmental health and aging,
as well as the active investigative projects in pharmacologi-
cal and biotechnological fields.
The PRBB will be housed in a new building, located be-
side the Hospital del Mar. It will have a building area of
28,000 square metres. This structure will house, among
other centres, the IMIM itself, the fully completed Depart-
ment of Experimental and Health Sciences of the UPF, and
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the future Centre of Genomic Regulation (a new research
centre promoted by the Department of Universities, Re-
search and Information Society of the Generalitat in collab-
oration with the UPF). The occasion will permit the opening
of a joint company of all the partners to efficiently provide
the necessary general and technical-scientific services for
a project of this sort. What is equally, if not more important,
it will be an unprecedented opportunity to initiate a cooper-
ative scientific project using resources from different institu-
tions. 
